GL1X · GenesisL1 explorer

Research workbench

Crystal structure of beta-lactamase penp mutant-E166Y in complex with cephaloridine as "post-acylation" intermediate

Analyse Crystal structure of beta-lactamase penp mutant-E166Y in complex with… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5ZG6
Type
protein
Length
512 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-lactamase
EC
3.5.2.6
UniProt
P00808
Ligands
CED
Pockets
4 · best druggability 0.73

Structure

x-ray diffraction · 1 distinct chain · 45% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
B, ABeta-lactamase (EC 3.5.2.6)protein25645% helix, 18% strandP00808

Ligands and binding sites

  • CED · 5-methyl-2-[2-oxo-1-(2-thiophen-2-yl-acetylamino)-ethyl]-3,6-dihydro-2H-[1,3]thiazine-4-carboxylic acid · ligand · 2 copies · chains B, A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111780.730.7799CED
2730.470.8317empty
3740.410.8018empty
4510.240.7315CED

Interfaces

1 interface between chains.

  • B–A · 620 Ų buried · 6 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent (covalent ligand).

Compared structures

  • 5ZG6 · Crystal structure of beta-lactamase PenP mutant-E166Y in complex with cephaloridine as… · the same entry in another collection · chain B against B, TM-score 1.00
  • P00808 · AlphaFold monomer V2.0 prediction for beta-lactamase (P00808) · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.